A recent article in the Guardian highlights the usage of two new performance enhancing drugs: GW1516 and Aicar. The article states that medical companies “are manufacturing (GW1516) without medical clearance. A single click reveals GW1516 to be the third highest-selling product on one internet site, at $119 for a 150-mg bottle.”
Who is buying this drug and making it such a top seller? Yes, some pros have been caught using it, but it takes a lot more sales to take it to number 3 on the sales charts.
Reading the comments reminds me that, just days before the start of the 100th Tour, cycling has lost almost all credibility among fans.